IMS has key therapy area expertise through IMS Management Consulting and related offerings.
We have expertise in working with our clients to help develop their portfolio in key therapy areas such as diabetes and oncology. It is estimated there are 190 million people with diabetes globally and prevalence is expected to reach 300 million in the next 20 years. Oncology will be the biggest therapeutic area by 2009.
This section of IMS Global Insights provides links to our expertise in these and other areas.